Sunmark Nicotine
NDC Package 64725-0691-1
Package Information
Sunmark Nicotine is if you are under 18 years of age, ask a doctor before use •before using this product, read the enclosed User’s Guide for complete directions and other important information •stop smoking completely when you begin using the gum •if you smoke your first cigarette within 30 minutes of waking up, use Nicotine Polacrilex Gum, 4 mg •if you smoke your first cigarette more than 30 minutes after waking up, use Nicotine Polacrilex Gum, 2 mg according to the following 12 week schedule: •Weeks 1 to 6Weeks 7 to 9Weeks 10 to 121 piece every 1 to 2 hours1 piece every 2 to 4 hours1 piece every 4 to 8 hoursnicotine gum is a medicine and must be used a certain way to get the best results •chew the gum slowly until it tingles. Marketed by Tya Pharmaceuticals, this product is identified by NDC 64725-0691 and is authorized under FDA application ANDA078325.
Identification & Billing
- RxCUI: 314119 - nicotine polacrilex 2 MG Chewing Gum
- RxCUI: 314119 - nicotine 2 MG Chewing Gum
- RxCUI: 314119 - nicotine 2 MG (as nicotine polacrilex 11.1 MG) Chewing Gum
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 64725 - Tya Pharmaceuticals
- 64725-0691 - Sunmark Nicotine
- 64725-0691-1 - 100 GUM, CHEWING in 1 BOX
- 64725-0691 - Sunmark Nicotine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64725-0691-1 identifies a specific commercial package of 100 gum, chewing in 1 box of Sunmark Nicotine, labeled by Tya Pharmaceuticals. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Tya Pharmaceuticals on June 23, 2005. The current certification is valid through December 31, 2017.
How is this Tya Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64725069101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.